NXL Nexalin Technology, Inc. - 8-K

Item 1.01

Entry into a Material Definitive Agreement.

On April 17, 2026, Nexalin Technology, Inc. (the “Company”)
entered into a Scope of Work (the “SOW”) with Lindus Health Limited (“Lindus Health”), a clinical research organization
based in the United Kingdom. The SOW is governed by a Master Services Agreement (“MSA”) previously entered into between the
parties and sets forth the terms under which Lindus Health will conduct the Company’s pivotal clinical trial for its HALO Clarity
device (the “Pivotal Study”).

Under the SOW, the Company will pay Lindus Health direct fees in an
aggregate amount of approximately $944,820, plus certain pass-through expenses. Payments of direct fees are structured on a milestone
basis, and pass-through expenses are invoiced on a monthly basis.

The term of the SOW continues until completion of all services described
therein, unless terminated earlier in accordance with the MSA. The SOW provides that certain changes to the Pivotal Study, such as addition
of new clinical sites, increases in enrolled participants, protocol amendments after study start-up, amendments to critical analyses,
extension of study duration, and requests for additional platform features or integrations, will require a change order, which may result
in adjustments to the scope, budget, or timeline.

The foregoing description of the SOW does not purport to be complete
and is qualified in its entirety by reference to the full text of the SOW, a copy of which will be filed as an exhibit to the Company’s
Form 10-Q for the quarter ended March 31, 2026.

Item
7.01

Other
Events.

On April 22, 2026, the Company issued a press release announcing the
advancement of its pivotal clinical trial evaluating the HALO Clarity device. A copy of this press release is attached hereto as Exhibit
99.1 and is incorporated by reference herein.

1

Item 9.01

Financial Statements and Exhibits.

Exhibit No.

Description

99.1

Press Release, dated April 22, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

2